Ocumension Therapeutics (HKG:1477)
Hong Kong · Delayed Price · Currency is HKD 4.955
-0.210 (-4.07%)
Nov 11, 2026, 4:08 PM HKT
Ocumension Therapeutics Market Cap
Ocumension Therapeutics has a market cap or net worth of 4.04 billion as of November 10, 2026. It is the 13,952nd most valuable company in the world and the 642nd biggest in Hong Kong. Its market cap has decreased by 43.05% in one year.
Market Cap
4.04B
Enterprise Value
3.77B
Revenue
1.08B
Global Rank
Country Rank
#642 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since July 10, 2020, Ocumension Therapeutics's market cap has decreased from 21.28B to 4.04B, a decrease of -81.02%. That is a compound annual growth rate of -23.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 4.04B | -33.04% |
| Dec 31, 2025 | 6.03B | 64.39% |
| Dec 31, 2024 | 3.67B | -20.44% |
| Dec 29, 2023 | 4.61B | -30.21% |
| Dec 30, 2022 | 6.61B | -43.35% |
| Dec 31, 2021 | 11.67B | -26.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lepu Biopharma | 5.35B |
| CK Life Sciences Int'l., (Holdings) | 5.14B |
| Ascletis Pharma | 4.97B |
| LongBio Pharma (Suzhou) | 4.35B |
| Abbisko Medicine | 4.17B |
| Jacobio Pharmaceuticals Group | 3.68B |
| Hanx Biopharmaceuticals (Wuhan) | 3.68B |
| TenNor Therapeutics (Suzhou) | 3.67B |